4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063300
SVP & Chief Financial Officer acquired 28,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2018-12-14 | Grant or award | +28,750 | 135,294 | D | ||
| Derivatives | |||||||
| Labrucherie Gil M SVP & Chief Financial Officer | 2018-12-14 | Grant or award · Stock Option | +58,100 | 58,100 | D | ||
Loading xslF345X03/doc4.xml…